219 related articles for article (PubMed ID: 23874679)
1. Assessment of motor function, sensory motor gating and recognition memory in a novel BACHD transgenic rat model for huntington disease.
Abada YS; Nguyen HP; Schreiber R; Ellenbroek B
PLoS One; 2013; 8(7):e68584. PubMed ID: 23874679
[TBL] [Abstract][Full Text] [Related]
2. Motor, emotional and cognitive deficits in adult BACHD mice: a model for Huntington's disease.
Abada YS; Schreiber R; Ellenbroek B
Behav Brain Res; 2013 Feb; 238():243-51. PubMed ID: 23123142
[TBL] [Abstract][Full Text] [Related]
3. A novel BACHD transgenic rat exhibits characteristic neuropathological features of Huntington disease.
Yu-Taeger L; Petrasch-Parwez E; Osmand AP; Redensek A; Metzger S; Clemens LE; Park L; Howland D; Calaminus C; Gu X; Pichler B; Yang XW; Riess O; Nguyen HP
J Neurosci; 2012 Oct; 32(44):15426-38. PubMed ID: 23115180
[TBL] [Abstract][Full Text] [Related]
4. Sexual behavior and testis morphology in the BACHD rat model.
Novati A; Yu-Taeger L; Gonzalez Menendez I; Quintanilla Martinez L; Nguyen HP
PLoS One; 2018; 13(6):e0198338. PubMed ID: 29883458
[TBL] [Abstract][Full Text] [Related]
5. Reversal learning and associative memory impairments in a BACHD rat model for Huntington disease.
Abada YS; Nguyen HP; Ellenbroek B; Schreiber R
PLoS One; 2013; 8(11):e71633. PubMed ID: 24223692
[TBL] [Abstract][Full Text] [Related]
6. BACHD rats expressing full-length mutant huntingtin exhibit differences in social behavior compared to wild-type littermates.
Manfré G; Novati A; Faccini I; Rossetti AC; Bosch K; Molteni R; Riva MA; Van der Harst JE; Nguyen HP; Homberg JR
PLoS One; 2018; 13(2):e0192289. PubMed ID: 29415038
[TBL] [Abstract][Full Text] [Related]
7. Motor deficits associated with Huntington's disease occur in the absence of striatal degeneration in BACHD transgenic mice.
Mantovani S; Gordon R; Li R; Christie DC; Kumar V; Woodruff TM
Hum Mol Genet; 2016 May; 25(9):1780-91. PubMed ID: 26908618
[TBL] [Abstract][Full Text] [Related]
8. Cognitive deficits in transgenic and knock-in HTT mice parallel those in Huntington's disease.
Farrar AM; Murphy CA; Paterson NE; Oakeshott S; He D; Alosio W; McConnell K; Menalled LB; Ramboz S; Park LC; Howland D; Brunner D
J Huntingtons Dis; 2014; 3(2):145-58. PubMed ID: 25062858
[TBL] [Abstract][Full Text] [Related]
9. Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice.
Gray M; Shirasaki DI; Cepeda C; André VM; Wilburn B; Lu XH; Tao J; Yamazaki I; Li SH; Sun YE; Li XJ; Levine MS; Yang XW
J Neurosci; 2008 Jun; 28(24):6182-95. PubMed ID: 18550760
[TBL] [Abstract][Full Text] [Related]
10. The BACHD Rat Model of Huntington Disease Shows Specific Deficits in a Test Battery of Motor Function.
Manfré G; Clemensson EKH; Kyriakou EI; Clemensson LE; van der Harst JE; Homberg JR; Nguyen HP
Front Behav Neurosci; 2017; 11():218. PubMed ID: 29163089
[No Abstract] [Full Text] [Related]
11. Reduced impact of emotion on choice behavior in presymptomatic BACHD rats, a transgenic rodent model for Huntington Disease.
Adjeroud N; Yagüe S; Yu-Taeger L; Bozon B; Leblanc-Veyrac P; Riess O; Allain P; Nguyen HP; Doyère V; El Massioui N
Neurobiol Learn Mem; 2015 Nov; 125():249-57. PubMed ID: 26463506
[TBL] [Abstract][Full Text] [Related]
12. Caspase-6 activity in a BACHD mouse modulates steady-state levels of mutant huntingtin protein but is not necessary for production of a 586 amino acid proteolytic fragment.
Gafni J; Papanikolaou T; Degiacomo F; Holcomb J; Chen S; Menalled L; Kudwa A; Fitzpatrick J; Miller S; Ramboz S; Tuunanen PI; Lehtimäki KK; Yang XW; Park L; Kwak S; Howland D; Park H; Ellerby LM
J Neurosci; 2012 May; 32(22):7454-65. PubMed ID: 22649225
[TBL] [Abstract][Full Text] [Related]
13. Behavioral and in vivo electrophysiological evidence for presymptomatic alteration of prefrontostriatal processing in the transgenic rat model for huntington disease.
Höhn S; Dallérac G; Faure A; Urbach YK; Nguyen HP; Riess O; von Hörsten S; Le Blanc P; Desvignes N; El Massioui N; Brown BL; Doyère V
J Neurosci; 2011 Jun; 31(24):8986-97. PubMed ID: 21677182
[TBL] [Abstract][Full Text] [Related]
14. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
[TBL] [Abstract][Full Text] [Related]
15. A Longitudinal Motor Characterisation of the HdhQ111 Mouse Model of Huntington's Disease.
Yhnell E; Dunnett SB; Brooks SP
J Huntingtons Dis; 2016 May; 5(2):149-61. PubMed ID: 27258586
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of SNARE-dependent gliotransmission on behavioral phenotypes in a mouse model of Huntington's disease.
King AC; Wood TE; Rodriguez E; Parpura V; Gray M
Exp Neurol; 2020 Aug; 330():113358. PubMed ID: 32387649
[TBL] [Abstract][Full Text] [Related]
17. Validation of behavioral phenotypes in the BACHD rat model.
Novati A; Manfré G; Flunkert S; Van der Harst JE; Homberg JR; Wronski R; Nguyen HP
Behav Brain Res; 2020 Sep; 393():112783. PubMed ID: 32574646
[TBL] [Abstract][Full Text] [Related]
18. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease.
Van Raamsdonk JM; Pearson J; Slow EJ; Hossain SM; Leavitt BR; Hayden MR
J Neurosci; 2005 Apr; 25(16):4169-80. PubMed ID: 15843620
[TBL] [Abstract][Full Text] [Related]
19. Marked differences in neurochemistry and aggregates despite similar behavioural and neuropathological features of Huntington disease in the full-length BACHD and YAC128 mice.
Pouladi MA; Stanek LM; Xie Y; Franciosi S; Southwell AL; Deng Y; Butland S; Zhang W; Cheng SH; Shihabuddin LS; Hayden MR
Hum Mol Genet; 2012 May; 21(10):2219-32. PubMed ID: 22328089
[TBL] [Abstract][Full Text] [Related]
20. Application of neurophysiological biomarkers for Huntington's disease: evaluating a phosphodiesterase 9A inhibitor.
Nagy D; Tingley FD; Stoiljkovic M; Hajós M
Exp Neurol; 2015 Jan; 263():122-31. PubMed ID: 25315303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]